UNIVERSITY of South Australia (UniSA) researchers have identified three new biomarkers for prostate cancer to help identify and differentiate aggressive cases of the disease, which kills more than 300,000 men each year.
An international team of scientists led by UniSA Prof of Molecular Medicine Doug Brooks said, "the biomarkers are remarkably sensitive and specific in accurately visualising the progress of the cancer and confirming its grade.
"In collaboration with Envision Sciences, this research has led to the development of a test which can determine how advanced & aggressive the cancer is, and whether immediate treatment is needed," shared Brooks.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Jul 23
